SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-14-403661
Filing Date
2014-11-07
Accepted
2014-11-07 17:16:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 424B3 d818209d424b3.htm 424B3 222160
  Complete submission text file 0001193125-14-403661.txt   223335
Mailing Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108
Business Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108 (801) 582-5400
Q Therapeutics, Inc. (Filer) CIK: 0001366541 (see all company filings)

IRS No.: 203708500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-182447 | Film No.: 141205872
SIC: 2834 Pharmaceutical Preparations